Core Viewpoint - The company, Seres, is set to become the first luxury new energy vehicle enterprise to be listed in both A and H shares, with its IPO scheduled from October 27 to 31, 2023, at a final price of HKD 131.50 per share, aiming to issue 8.419 million additional shares [1] Group 1: Company Performance and Market Position - Seres has seen significant growth in its sales since the launch of the Aito brand in 2021, with sales figures reaching 77,900 units in 2022 and projected to hit 388,700 units by mid-2025, making up 90.3% of the company's revenue in the first half of 2025 [2] - The company is expected to maintain its position as the third-largest player in the luxury new energy vehicle market in 2024, with its models, the Aito M7 and M9, ranking among the top five in sales [1][2] Group 2: Technological and Operational Strengths - Seres boasts four key technological strengths, including the self-developed Seres Magic Cube technology platform and the next-generation Seres Super Range Extender system, which contribute to its competitive edge in the industry [3] - The company has established a robust service support system across over 400 user centers and 700 experience centers in more than 220 cities, enhancing customer satisfaction and brand loyalty [3] Group 3: Future Outlook and Valuation - The company is expected to continue its growth trajectory, with projections indicating a doubling of revenue in 2024, driven by the popularity of the Aito models [3][4] - With a strong market presence and favorable investor sentiment, Seres is anticipated to achieve a significant valuation increase post-IPO, potentially leading to a tenfold market cap growth in the coming years [4]

Core Viewpoint - The company, Seres, is set to launch its IPO on the Hong Kong Stock Exchange, aiming to raise capital and become the first luxury new energy vehicle company listed in both A and H shares, with a share price set at HKD 131.50 [1] Group 1: IPO Details - Seres plans to globally offer 100.2 million H shares, with 10.02 million shares available for public sale in Hong Kong and approximately 90.18 million shares for international sale [1] - The IPO is scheduled for subscription from October 27 to 31, with the listing date set for November 5 [1] - The Hong Kong IPO market has seen a surge, with 12 new stocks having subscription multiples exceeding 2000 times in the second half of the year [1] Group 2: Market Position and Performance - Seres is projected to maintain a third-place market share in the luxury new energy vehicle sector in 2024, with its models, the Wanjie M7 and M9, ranking among the top five in sales [1] - The Wanjie brand has shown significant sales growth since its launch in 2021, with sales figures of 77,900 units in 2022, 102,600 units in 2023, and 388,700 units in the first half of 2025, contributing 90.3% of the company's revenue in the same period [2] Group 3: Competitive Advantages - The company's success is attributed to its strong technological capabilities, including proprietary technologies and a deep partnership with Huawei, enhancing its competitive edge in the market [3] - Seres has established a robust service support system and has built over 400 user centers and 700 experience centers across more than 220 cities, ensuring efficient delivery and customer satisfaction [3] Group 4: Future Outlook - The company is expected to continue its growth trajectory, with projections of doubling revenue in 2024 and achieving profitability, distinguishing itself from competitors who are generally in loss [3] - With the anticipated launch of the Wanjie M8 in April 2025, Seres is expected to solidify its market position in the high-end segment, driving further sales growth [4] - The company's strong performance in the A-share market, with a market value increase of over 14 times since 2020, suggests a positive outlook for its upcoming H-share listing [4]

假设全球发售于2025年11月5日(星期三)上午八时正(香港时间)或之前成为无条件，预期H股将于2025年 11月5日(星期三)上午九时正(香港时间)在联交所主板开始买卖。H股将以每手买卖单位100股H股买卖。 格隆汇11月2日丨赛力斯(09927.HK)公布，发售价已于2025年10月31日厘定为每股H股131.50港元(不包 括1%经纪佣金、0.0027%证监会交易征费、 0.00565%联交所交易费及0.00015%会财局交易征费)。 本公司预期将于2025年11月4日(星期二)以招股章程"如何申请香港发售股份 -公布结果"一节所述的方式 公布国际发售的踊跃程度、香港公开发售的申请水平、香港发售股份的分配基准及香港公开发售的分配 结果的详情。 发售量调整权已获部分行使，据此，本公司将按发售价发行及配发841.9万股额外发售股份，占全球发 售项下初步可供认购的发售股份总数的约8.40%。根据发售量调整权发行及配发的额外发售股份将根据 香港公开发售与国际发售之间的初始比例10.0%:90.0%予以分配。 ...

Core Viewpoint - The company, Seres (09927), has set the offering price for its H-shares at HKD 131.50 per share, excluding various fees [1] Group 1: Offering Details - The company will issue and allocate an additional 8.41 million shares, which represents approximately 8.40% of the total shares available for subscription under the global offering [1] - The additional shares will be allocated based on the initial ratio of 10.0% for the Hong Kong public offering and 90.0% for the international offering [1] Group 2: Timeline and Trading - The company expects to announce the level of interest in the international offering and the application level for the Hong Kong public offering on November 4, 2025 [1] - If the global offering becomes unconditional by November 5, 2025, trading of the H-shares is anticipated to commence on the Hong Kong Stock Exchange at 9:00 AM [1] - H-shares will be traded in board lots of 100 shares [1]

本公司预期将于2025年11月4日(星期二)以招股章程"如何申请香港发售股份 -公布结果"一节所述的方式 公布国际发售的踊跃程度、香港公开发售的申请水平、香港发售股份的分配基准及香港公开发售的分配 结果的详情。 假设全球发售于2025年11月5日(星期三)上午八时正(香港时间)或之前成为无条件，预期H股将于2025年 11月5日(星期三)上午九时正(香港时间)在联交所主板开始买卖。H股将以每手买卖单位100股H股买卖。 发售量调整权已获部分行使，据此，本公司将按发售价发行及配发841.9万股额外发售股份，占全球发 售项下初步可供认购的发售股份总数的约8.40%。根据发售量调整权发行及配发的额外发售股份将根据 香港公开发售与国际发售之间的初始比例10.0%:90.0%予以分配。 格隆汇11月2日丨赛力斯(09927.HK)公布，发售价已于2025年10月31日厘定为每股H股131.50港元(不包 括1%经纪佣金、0.0027%证监会交易征费、 0.00565%联交所交易费及0.00015%会财局交易征费)。 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表聲明，並明確表示概不 會就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 本公告不得直接或間接於或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發或派發。本公告並不構成或組成在美國境內或於任何其他司法管轄區購買或認購發售股 份的任何要約或招攬的一部分。發售股份並無亦不會根據《1933年美國證券法》（經不時修訂） （「美國證券法」）或美國任何州或其他司法管轄區的證券法登記。發售股份不得在美國境內提呈 發售、出售、質押或以其他方式轉讓，惟根據美國證券法的登記規定獲豁免及遵守任何適用的 州證券法，或根據美國證券法S規例在美國境外向非美國人士投資者或並非為美國人士或為其 利益進行收購的投資者提呈發售、出售、質押或轉讓。發售股份不會在美國公開發售。 公佈發售價 茲提述本公司於2025年10月27日刊發的招股章程。發售價已於2025年10月31 日釐定為每股H股131.50港元（不包括1%經紀佣金、0.0027%證監會交易 ...

Major Events - Silyus (09927) starts its public offering with cornerstone subscriptions amounting to $826.5 million, with 70% of the funds allocated for R&D [1] - Dipo Technology (01384) sees a public offering in Hong Kong oversubscribed by 7569.83 times, raising approximately HK$609.8 million from the global offering [1] - Bama Tea (06980) experiences a public offering in Hong Kong oversubscribed by 2680.04 times, with a share price set at HK$50 [1] - Cambridge Technology (06166) has its public offering in Hong Kong oversubscribed by 338.7 times, with a share price of HK$68.88 [1] - Sany Heavy Industry (06031) reports a public offering in Hong Kong oversubscribed by 52.93 times, netting approximately HK$13.307 billion from the global offering [1] - Kangzhe Pharmaceutical (00867) signs a distribution agreement with Novartis for ophthalmic drugs [1] - Postal Savings Bank of China (01658) is approved to establish a financial asset investment company [1] - Meidong Automotive (01268) invests $20 million to subscribe for shares in Silyus [1] - China Aluminum (02600) plans to increase capital in Yunnan Aluminum Foil by a total of 906.45 million yuan through cash or asset contributions from subsidiaries [1] - China Coal Energy (01898) subsidiary intends to acquire the remaining 30% stake in a new energy company for 115 million yuan [1] - China Software International (00354) successfully signs a project for the Wuhan Cybersecurity Base Intelligent Computing Center, promoting AI industry development in Wuhan [1] - China Gold International (02099) is included in the Hang Seng Hong Kong Chinese Enterprises Index [1] - Beike-W (02423) has its MSCI ESG rating upgraded to "AA" [1] Operating Performance - China National Pharmaceutical Group (01099) reports a net profit of approximately 5.307 billion yuan for the first three quarters, a year-on-year increase of 0.53% [2] - Qingdao Beer Co. (00168) announces a net profit of 5.274 billion yuan for the first three quarters, up 5.7% year-on-year [2] - Yuehai Investment (00270) reports a net profit of 4.067 billion HKD for the first three quarters, a 13.2% increase year-on-year [2] - China Southern Airlines (01055) posts a net profit of 2.307 billion yuan for the first three quarters, a year-on-year growth of 17.4% [2] - Zhongchuang Zhiling (00564) announces a net profit of 3.645 billion yuan for the first three quarters, up 19.17% year-on-year [2] - China Aluminum (02600) reports a net profit of 10.872 billion yuan for the first three quarters, a 20.65% increase year-on-year [2] - Heng Rui Pharmaceutical (01276) announces a net profit of 5.751 billion yuan for the first three quarters, a year-on-year increase of 24.5% [2] - Jihong Co. (02603) reports a net profit of 216 million yuan for the first three quarters, a significant increase of 60.11% year-on-year [2] - China Foreign Transport (00598) announces a net profit of 2.679 billion yuan for the first three quarters, down 5.17% year-on-year [2] - China Coal Energy (01898) reports a net profit of 12.485 billion yuan for the first three quarters, a decline of 14.6% year-on-year [2] - Fuyao Glass (06865) announces a net profit of 638 million yuan for the first three quarters, down 50.79% year-on-year [2] - Fenmei Packaging (00468) reports a profit attributable to equity holders of 76.982 million yuan for the first nine months, a decrease of 59.13% year-on-year [2] - CanSino Biologics (06185) announces a net profit of 14.44 million yuan for the first three quarters [2] - Wuzhou Real Estate (00230) reports a contract sales amount of approximately 3.22 billion yuan for the first nine months, a year-on-year decline of about 24.2% [2] Retail Performance - Anta Sports (02020) reports a low single-digit positive growth in retail sales for its Anta brand products in the third quarter [3]

賽力斯集團股份有限公司 Seres Group Co., Ltd. （於中華人民共和國註冊成立的股份有限公司） 股份代號 : 9927 全球發售 聯席保薦人、整體協調人、聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 重要提示 重要提示： 倘閣下對本招股章程的任何內容有任何疑問，應諮詢獨立專業意見。 Seres Group Co., Ltd. 賽力斯集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 全球發售 | 全球發售的發售股份數目 | : | 100,200,000股H股（視乎發售量調整權 | | --- | --- | --- | | | | 及超額配股權行使與否而定） | | 香港發售股份數目 | : | 10,020,000股H股（可予重新分配 | | | | 及視乎發售量調整權行使與否而定） | | 國際發售股份數目 | : | 90,180,000股H股（可予重新分配、 | | | | 視乎發售量調整權及超額配股 | | | | 權行使與否而定） | | 最高發售價 | : | 每股H股131.50港元，另加1.0%經紀 | | | | ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表聲明，並明確表示概不 會就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 本公告不得直接或間接於或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發或派發。本公告並不構成或組成在美國境內或於任何其他司法管轄區購買或認購發售股 份的任何要約或招攬的一部分。發售股份並無亦不會根據1933年《美國證券法》（經不時修訂） （「美國證券法」）或美國任何州或其他司法管轄區的證券法登記。發售股份不得在美國境內提呈 發售、出售、質押或以其他方式轉讓，惟根據美國證券法的登記規定獲豁免及遵守任何適用的 州證券法，或根據美國證券法S規例在美國境外向非美國人士投資者或並非為美國人士或為其 利益進行收購的投資者提呈發售、出售、質押或轉讓。發售股份不會在美國公開發售。 本公告僅作說明用途，並不構成收購、購買或認購證券的邀請或要約。本公告並非招股章程。 潛在投資者於決定是否投資所提呈發售的H股前，應閱覽賽力斯集團股份有限公司（「本公司」） 刊 ...